Streptococcus pneumoniae is a bacterial micro-organism that frequently causes serious infection, particularly in children and the elderly. Protection against infection with S. pneumoniae is mainly based on the generation of antibodies to the pneumococcal capsular polysaccharides (caps-PS) but the mechanisms responsible for the generation on anti-capsular antibodies remain incompletely understood. The aim of the present study was to evaluate the role of CD1-restricted T cells in the antibody response to caps-PS.
Introduction
Streptococcus pneumoniae is a major human pathogen. Infections with S. pneumoniae result in substantial morbidity and mortality, particularly in young children, the elderly and immunocompromised patients (26). In various animal species and in humans, protection against S. pneumoniae infection is mediated by antibodies against pneumococcal capsular polysaccharides (caps-PS) and surface proteins (2, 4) .
Caps-PS are classified as T lymphocyte-independent type 2 (TI-2) antigens (24) . While T lymphocytes are not required for the generation of antibody responses against TI-2 antigens, they can influence the antibody response to these antigens (24) . In the case of caps-PS, the role of T lymphocytes in the generation of antibody responses might be more important than was initially thought. There is now evidence that T lymphocytes may support the antibody response to TI-2 antigens via several pathways (14) . The magnitude of the antibody response to caps-PS is regulated both positively and negatively by distinct subsets of thymus-derived T-lymphocytes. It has been reported that CD4 + T-cells have positive effects on the antibody response to caps-PS, whereas CD8 + T-cells have a suppressive effect. The presence of these two distinct types of T-cells with opposing regulatory functions with respect to the immune response to soluble caps-PS has been demonstrated in vivo in mice and in in vitro with human lymphocytes (1, 8, 10 ) . SCID/SCID mice reconstituted with B lymphocytes and CD4 + T lymphocytes mounted a higher specific IgM antibody response to soluble pneumococcal caps-PS than SCID/SCID mice reconstituted with only B lymphocytes (12, 15) . Murine spleen cells depleted of CD8 + T lymphocytes mounted a higher immune response to soluble caps-PS than total murine spleen cells, whereas spleen cells depleted of CD4 + T cells elicited only a weak antibody response (15) . Similarly, the human IgM and IgG antibody response to soluble pneumococcal caps-PS was strongly dependent on CD4 + T cells (13) . Several reports
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on November 12, 2017 by guest http://iai.asm.org/ Downloaded from have provided evidence that CD4 + T cells enhance the IgG antibody response to pneumococcal polysaccharides after immunization of mice with intact S. pneumoniae (19, 37) . The anti-polysaccharide antibody response after immunization with conjugated polysaccharide serotype 3 was higher in CD8-deficient mice compared to control mice, a finding attributed to CD8 T lymphocyte-mediated suppression of the anti-polysaccharide immune response (34) .
In a provocative study, Kobrynski et al. (20) reported that CD1-restricted T cells and MHC class I-dependent CD8 + cells are essential for the anti-caps-PS immune response. These findings set forth a new paradigm for humoral responses to caps-PS in which CD1 expression as well as a subset of CD8 + cells are required to provide helper function for antibody production against TI-2 caps-PS, akin to the role of MHC class II-restricted CD4 + cells for the generation of antibody responses to protein antigens (20) . The MHC class I-like protein CD1 is expressed on antigen presenting cells and is required for the presentation of lipids and glycolipids to T lymphocytes (25, 28, 29) .
The findings of Kobrynski et al. (20) , suggesting that CD8 + T-cells are essential for the IgG antibody response to capsular polysaccharides, are at odds with many other experimental data (1, 8, 10, 12, 13, 15, 19, 34, 37) that support the concept that CD4 + T-cells have a positive effect on the anti-polysaccharide immune response. Because of this controversy and because Verhaegen, Laboratory Medicine, University Hospital Leuven, Belgium, 2x10 8 CFU). The vaccine was 1/25 diluted in NaCl 0.9%. Five hundred µl of this diluted vaccine was given i.p.
After 14 days, blood was drawn by cardial puncture and anti-caps-PS antibodies were detected by ELISA. In experiments in which the effects of the anti-CD1 antibody 20H2 were studied, 500 µg of 20H2 was injected i.p. one day before immunization with Pneumo23 ® .
Five hundred µg of hamster IgG control antibody was injected i.p. in the control group.
ELISA for detection of anti-caps-PS antibodies.
Anti-caps-PS antibodies were detected as previously described (23) . Briefly, a Covalink The D1 cell line, a long-term growth factor-dependent immature splenic dendritic cell line derived from B6 mice, was cultured as described (36) .
Statistical analysis.
Differences in antibody levels were evaluated by Mann-Whitney U test. 
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Results
To study the role of CD1 expression in presenting caps-PS to T lymphocytes, the anti-caps-PS antibody response was studied in CD1 knock out mice. Control mice and CD1 knock out mice on a Balb\c and on a C57bl6 background were immunized with Pneumo23 ® and the antibody response to caps-PS was measured two weeks later. As shown in Figure 1 (panel B and panel C), the IgM as well as the IgG anti-caps-PS antibody response to serotype 3 and serotype 4 was not significantly different in CD1 knock out and wild type mice. Similar results were found for other serotypes (serotype 1, 9N, and 14) (data not shown).
Next, we also evaluated the effect of anti-CD1 antibody (20H2) treatment on the antibody response to Pneumo23 ® . Anti-CD1 monoclonal antibody has previously been shown to affect listeriosis in mice (22) . In order to confirm that the 20H2 antibody was effective in blocking CD1 function, we investigated whether 20H2 was able to inhibit cytokine production by CD1restricted natural killer T cells in response to stimulation with the potent agonist αgalactosylceramide (23) . For this purpose, we measured the effect of 20H2 on interferon-γ production after stimulation of spleen cells cultured with D1 dendritic cells in the presence of α-galactosylceramide. The results are shown in Figure 2 and illustrate that 20H2 strongly inhibited α-galactosylceramide-mediated interferon-γ production.
Results of the in vivo experiments in which we evaluated the effect of anti-CD1 treatment on
the anti-caps-PS immune (serotype 3) response are shown in Figure 1 Similar results were found for serotype 4. Taken together, these data suggested that CD1 expression is not required for the overall antibody response to caps-PS.
Finally, we studied the immune response to inactivated intact S. pneumoniae serotype 3 in C57bl6 CD1 knock-out mice and in control mice. In intact S. pneumoniae serotype 3, the polysaccharides are presented as part of a whole organism, whereas in Pneumo23 ® , the polysaccharides are presented as soluble antigens. The IgM and IgG antibody response to serotype 3 in intact S. pneumoniae was comparable in CD1 knock-out mice and control mice ( Figure 1, panel D) . Similar results were found for serotype 14 (results not shown).
Taken together, our results indicate that CD1 expression does not play an important role in the immune reaction to caps-PS, independent of the way the antigen is presented.
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Discussion
CD1 molecules are expressed on antigen presenting cells and are known to present lipids and glycolipids to CD4 + and CD4 -CD8 -T lymphocytes (17, 30) . CD1 molecules are associated with β2-microglobulin, a characteristic shared with classical MHC class I proteins, with which they share sequence homology (7) . The naturally occurring CD1-presented antigens appear to be lipids or glycolipids (31) . The crystal structure of CD1 indicates that the lipid tail of the antigen anchors into the hydrophobic cavity of CD1, leaving the hydrophilic saccharide groups protruding from the CD1 molecule and accessible for interactions with T lymphocytes (3, 31) .
Kobrynski et al. found that CD1 knock-out mice were severely deficient in IgG production to caps-PS, suggesting a role of CD1 in the presentation of caps-PS by antigen presenting cells to T lymphocytes (20) . We found (i) that the anti-caps-PS immune response in CD1 KO animals was comparable to the response in wild type animals and (ii) that administration of a blocking anti-CD1 antibody did not affect the anti-caps-PS immune response. Taken together, our data indicate that CD1 expression does not influence the antibody immune response to caps-PS. This is in line with the ultrastructure of the CD1 molecule that has a large hydrophobic groove which binds the hydrophobic part of the presented antigen (38) . Taken together, the role of CD1 in the antibody production to pneumococcal caps-PS is controversial. It is unclear how these different observations with respect to the role of CD1 and the role of CD8(+) T cells might be explained. Few data on this issue is available in the literature. It has been reported that the macrophage-mediated clearance of Pseudomonas aeruginosa from lung is CD1d-dependent (27) . Moreover, Kawakami reported a critical role of Vα14(+) CD1(+) natural killer T cells in the innate phase of host protection against S. pneumoniae (18).
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The mechanism by which T lymphocytes are activated by caps-PS and antigen presenting cells remains largely undefined. It is generally believed that caps-PS do not bind to MHC-II molecules (11) . This was confirmed in studies using MHC-II deficient mice, which had normal antibody responses to TI-2 antigens (6). Furthermore, it was shown that allogeneic T lymphocytes were able to stimulate the anti-caps-PS antibody response (9). Cobb et al. (5) , however, found that zwitterionic polysaccharides (e.g. caps-PS serotype 1) are processed to low-molecular-weight carbohydrates by a nitric-oxide-dependent mechanism in endosomes and bind to MHC-II inside antigen presenting cells. These antigens elicited a potent CD4 + T cell response in vitro and in vivo (16) , which required direct interaction of T cells with HLA-DR bearing antigen presenting cells. The immune response to zwitterionic polysaccharides depends on the translocation of HLA-DR to the cell surface and requires costimulation via B7-2 and CD40 on activated antigen presenting cells (32) . In the present paper, we provide evidence that the antibody response to caps-PS is generated independently of CD1 expression. 
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